bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.02.23.581779

A generic noninvasive neuromotor interface for human-computer interaction

Abstract

Since the advent of computing, humans have sought computer input technologies that are expressive, intuitive, and universal. While diverse modalities have been developed, including keyboards, mice, and touchscreens, they require interaction with an intermediary device that can be limiting, especially in mobile scenarios. Gesture-based systems utilize cameras or inertial sensors to avoid an intermediary device, but they tend to perform well only for unobscured or overt movements. Brain computer interfaces (BCIs) have been imagined for decades to solve the interface problem by allowing for input to computers via thought alone. However high-bandwidth communication has only been demonstrated using invasive BCIs with decoders designed for single individuals, and so cannot scale to the general public. In contrast, neuromotor signals found at the muscle offer access to subtle gestures and force information. Here we describe the development of a noninvasive neuromotor interface that allows for computer input using surface electromyography (sEMG). We developed a highly-sensitive and robust hardware platform that is easily donned/doffed to sense myoelectric activity at the wrist and transform intentional neuromotor commands into computer input. We paired this device with an infrastructure optimized to collect training data from thousands of consenting participants, which allowed us to develop generic sEMG neural network decoding models that work across many people without the need for per-person calibration. Test users not included in the training set demonstrate closed-loop median performance of gesture decoding at 0.5 target acquisitions per second in a continuous navigation task, 0.9 gesture detections per second in a discrete gesture task, and handwriting at 17.0 adjusted words per minute. We demonstrate that input bandwidth can be further improved up to 30% by personalizing sEMG decoding models to the individual, anticipating a future in which humans and machines co-adapt to provide seamless translation of human intent. To our knowledge this is the first high-bandwidth neuromotor interface that directly leverages biosignals with performant out-of-the-box generalization across people.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ctrl-labs at Reality Labs,, Sussillo, D., Kaifosh, P., Reardon, T.. 2024-02-28. A generic noninvasive neuromotor interface for human-computer interaction. https://doi.org/10.1101/2024.02.23.581779

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗